Chilmark Research October 15, 2020
Jody Ranck

While COVID-19 has been dominating the healthcare headlines so far in 2020 there have been a number of recent policy and regulatory decisions bearing on the AI/ML market in healthcare. We have been reading quite a bit about the broader slowdown in the market for AI/ML developers since the pandemic began that may be a temporary disruption to some parts of the market. On the other hand, CMS and the FDA have made some moves that may be part of building a stronger foundation for the market in AI applications, at least in clinical decision support and radiology/medical imaging segments of the market. We have also seen some major bets placed on AI-based companies that are riding on the wave...

Today's Sponsors

HealthSnap
Canton & Company
oscar

Today's Sponsors

oscar
AlphaHealth

Today's Sponsor

Healthcare NOW Radio

2020-10-15T22:09:14-04:00